Skip to main content

Table 2a Application to the MSAC and Duration of Assessment

From: The Australian experiment: the use of evidence based medicine for the reimbursement of surgical and diagnostic procedures (1998–2004)

App.

Description

First MSAC Meeting

MSAC Meeting – Endorsed

Minister Sign Off

Duration in Months

MSAC Outcome

1001

Advanced breast biopsy instrumentation

May'98

 

May'99

12

Negative

1002

Oto-acoustic emission audiometry

May'98

 

Aug'99

15

Positive

1003

OctreoScan¨ scintigraphy for gastro-entero-pancreatic neuroendocrine tumours

May'98

 

Aug'99

15

Positive

1004

Transmyocardial laser revascularization

May'98

Aug'99

Sept'99

16

Negative

1005

Visual electrodiagnosis

May'98

May'01

Jun'01

25

Partial

1006

Endoluminal grafting for abdominal aortic aneurysm

May'98

 

May'99

12

Partial

1007

Saline infusion sonohysterography

May'98

 

May'99

12

Positive

1008

Photodynamic therapy for skin and mucosal cancer

May'98

 

May'99

12

Negative

1009

Sacral nerve stimulation for urinary incontinence

May'98

 

Mar'00

22

Negative

1010

Intravascular extraction of chronically implanted permanent transvenous pacing leads

Sept'98

Aug'99

Sept'99

12

Positive

1011

Lung volume reduction surgery – for advanced emphysema

Sept'98

Feb'01

Apr'01

19

Negative

1012

Vertebral axial decompression therapy for chronic back pain

Feb'99

May'01

Jun'01

28

Negative

1013

Treatment of diseases of the inner ear using the Round Window Microcath System

Aug'99

  

-

Ineligible

1014

TransUrethral Needle Ablation for benign prostatic hyperplasia

May'99

Nov'01/Mar'02

May'02

36

Interim

1015

Directional, vacuum-assisted breast biopsy

May'98

Aug'99

Sept'99

16

Interim

1016

Samarium153-lexidronam for bone pain due to skeletal metastases

May'98

 

Aug'99

15

Positive

1017

Chelation therapy – for cardiovascular disease

Nov'98

  

-

Ineligible

1018–1020

Hyperbaric oxygen treatment

May'99

 

Feb'01

21

Partial

1022

Commercial-in-Confidence Application

May'99

  

-

Ineligible

1023

Placement of artificial bowel sphincters in the management of faecal incontinence

May'99

Nov'99

Nov'99

12

Negative

1024

Total ear reconstruction

May'99

 

Mar'00

10

Positive

1025

Provision of Positron Emission Tomography (PET) services – deferred. See Reference 02

Aug'99

 

Aug'00

12

Ref 02

1026

Near patient cholesterol testing using the Cholestech LDX

Aug'99

Aug'01

Sept'01

25

Interim

1027

Provision of Positron Emission Tomography (PET) services – deferred. See Reference 02

Aug'99

  

-

Ref 02

1028

Gamma knife surgery

Nov'99

Nov'00

Aug'01

21

Negative

1029

Brachytherapy for the treatment of prostate cancer

Nov'99

Nov'00

Feb'01

15

Interim

1030

Low intensity ultrasound treatment for the acceleration of bone fracture healing – Exogen\texttrademark bone growth stimulator

Feb'00

Nov'01

Feb'02

24

Negative

1031

Deep brain stimulation for symptoms of advanced Parkinson's disease

May'00

May'01

Jun'01

13

Interim

1032

Intravascular ultrasound

May'00

Mar'02

May'02

24

Negative

1033

Autogenous cartilage implantation

May'00

  

?

On hold

1034

Selective Internal Radiation Therapy for hepatic Metastases using SIR-Spheres®

May'00

Nov'01/Mar'02

Aug'02

27

Negative

1035

Genetic test for Fragile X syndrome

May'00

Mar'02

Aug'02

27

Positive

1036

Percutaneous transluminal coronary rotational atherectomy for lesions of the coronary arteries

Aug'00

 

Sept'02

25

Partial

1037

Advanced breast biopsy instrumentation (Note earlier application 1001)

Aug'00

Aug'01

Sept'01

13

Positive

1038

Conformal radiotherapy

Aug'00

Nov'01

Feb'02

18

Positive

1039

Photodynamic therapy with verteporfin for macular degeneration

Nov'00

Aug'01

Sept'01

10

Partial

1040

Anatomical biomodelling

Nov'00

  

-

Ineligible

1041

Intravascular Brachytherapy – Commercial-in-Confidence application

May'01

Aug'02

Oct'02

17

Interim

1042

Cardiac resynchronisation therapy (CRT)

May'01

Aug'05

 

55+

Positive

1043

Thyrogen\texttrademark (thyrotropin alfa) as a diagnostic agent for well-differentiated thyroid cancer

May'01

Aug'02

Oct'02

17

Negative

1044

Ostase immunoassay for the mass measurement of serum bone alkaline phosphatase

May'01

May'03

Aug'03

27

Negative

1045

Intra-articular viscosupplementation for treatment of osteoarthritis of the knee

Aug'01

 

Mar'03

19

Negative

1046

Interstim for sacral nerve stimulation in patients with refractory urinary incontinence

Aug'01

Jun'02

 

11+

Negative

1047

Endoluminal Gastroplication for the treatment of Gastro-Oesophageal Reflux Disease GORD

Aug'01

 

Jun'02

10

Negative

1048

Intradiscal electrothermal anuloplasty for patients with chronic low back pain due to anular disruption of contained herniated discs

Aug'01

Nov'02

Dec'02

16

Negative

1049

M-VAX TM – a treatment for patients with advanced stage III melanoma

Nov'01

Aug'02

Oct'02

11

Negative

1050

Optical Biometry

Nov'01

Mar'03/Aug'03

Jun'04

31

Positive

1051

Vacuum Assisted Closure (VAC) Therapy

Nov'01

  

-

Ineligible

1052

Radiofrequency ablation of liver tumours

Nov'01

May'03

Aug'03

21

Partial

1053

Placement of artificial bowel sphincters in the management of faecal incontinence

Mar'02

May'03

?

14+

Negative

1054

Hyperbaric Oxygen Therapy (Resubmission)

Mar'02

May'03/Aug'03

Aug'04

29

Interim

1055

Hysteroscopic sterilisation by tubal cannulation and placement of intrafallopian implants

Mar'02

Nov'03

Mar'05

36

Negative

1056

LeukoScan®

May'02

May'03

Aug'03

15

Partial

1057

M2A® capsule endoscopy – evaluation of obscure gastrointestinal bleeding in adult patients

Aug'02

Aug'03

Sept'03

16

Interim

1058

QuantiFERON-TB Gold

 

Aug'04

 

-

Withdrawn

1059

Endo Venous Laser Treatment for Varicose Veins

Mar'03

Nov'03

Aug'04

17

Negative

1060

Bone Mineral Densitometry – Reference 19

Mar'03

Nov'04

 

-

Withdrawn

1061

Implantation of Insertable Loop Recorder for Diagnosis of Recurrent Unexplained Syncope

Mar'03

Nov'03

 

8+

Positive

1062

A scan for Imaging Recurrence and/or metastases in patients with histologically demonstrated carcinoma of the colon or rectum

Mar'03

May'04

Aug'04

17

Negative

1063

Photodynamic Therapy for Verteporfin (Visudyne) for Subfoveal choroidal neovasculanisations (Commercial in Confidence)

Mar'03

Nov'03

Mar'05

24

Unchanged

1064

Three dimensional magnetic electroanatomical radiofrequency ablation for the treatment of cardiac arrhythmia's

Mar'03

  

-

Ineligible

1065

Sentinel Node Biopsy for Breast Cancer

Mar'03

Mar'05

Jul'05

28

Interim

1066

Drug (Sirolimus) Eluting Stents ("Commercial-in-Confidence") – Refer to Reference 21

Mar'03

Aug'03

Sept'03

-

Ref 21

1067

Genotypic resistance testing of antiretrovirals in HIV

Aug'03

Aug'04

Mar'05

19

Negative

1068

Prostate specific antigen (PSA) test

Mar'04

Mar'05

Jul'05

16

Unchanged

1069

Endoscopic ultrasound for the pre-operative staging of gastric and oesophageal neoplasms – Refer to Application 1072

Mar'04

  

21+

App 1072

1070

An innovative patent for tobacco smoking cessation

Mar'04

  

-

Ineligible

1071

Measurement of international normalised ratio (INR) in general practice

Mar'04

May'05

Jul'05

16

Negative

1072

Endoscopic ultrasound for staging pancreatic, gastric, oesophageal and hepato-biliary neoplasms

Mar'04

  

21+

Incomplete

1073

METVIX (Commercial-in-confidence) – referred to the PBAC

Mar'04

   

Withdrawn

1074

Freelight Lambda and Freelight Kappa

Mar'04

  

-

Withdrawn

1075

Endoscopic ultrasound for the diagnosis and pre-operative staging of Hepato-biliary neoplasms – Refer to Application 1072

Mar'04

  

21+

Incomplete

1076

Transurethral microwave thermotherapy (TUMT)

May'04

  

19+

Positive

1077

Sacral nerve stimulation for faecal incontinence

May'04

May'05

Jul'05

14

Positive

1078

Multifocal multichannel objective perimetry (MMOP)

May'04

Aug'04

 

3+

Negative

1079

Peripheral arterial tonometry with ascending aortic waveform analysis using the SphygmoCor system

May'04

Mar'06

 

19+

Incomplete

1080

Radi pressure wire

Aug'04

Nov'05

 

16+

Incomplete

1081

Uterine artery embolisation

Aug'04

  

16+

Incomplete

1082

SIR-Spheres® for the treatment of non-resectable liver tumours

Aug'04

  

11+

Interim

1083

Intac Implants

Aug'04

  

11+

Negative

1084

Uro Vysion

Aug'04

Nov'05

 

16+

Incomplete

1085

Carbon labelled urea breath test

Nov'04

  

13+

Incomplete

1087

B-Type Natriuretic Peptide – includes 1086

Aug'04

  

16+

Incomplete

1089

Brachytherapy for the treatment of prostate cancer

Nov'04

May'05

Jul'05

8

Interim

1090

Artificial intervertebral disc replacement – previously Reference 29

Mar'04

Nov'05

 

14+

Incomplete

1091

Minimally Invasive Robotic Assisted Radical Prostatectomy

Mar'05

  

9+

Incomplete

1092

Deep brain stimulation for the symptoms of Parkinson's disease

Mar'05

  

9+

Incomplete

1093

Endovascular Neurointerventional Procedures

Mar'05

  

9+

Incomplete

  1. Source: MSAC Web Site: http://www7.health.gov.au/msac/ – Accessed 6th Jan'06 Correct as at end Dec'05